PP2A and GSK-3β act antagonistically to regulate active zone development

Natasha M. Viquez, Petra Füger, Vera Valakh, Richard W. Daniels, Tobias M. Rasse, Aaron DiAntonio

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

The synapse is composed of an active zone apposed to a postsynaptic cluster of neurotransmitter receptors. Each Drosophila neuromuscular junction comprises hundreds of such individual release sites apposed to clusters of glutamate receptors. Here, we show that protein phosphatase 2A (PP2A) is required for the development of structurally normal active zones opposite glutamate receptors. When PP2A is inhibited presynaptically, many glutamate receptor clusters are unapposed to Bruchpilot (Brp), an active zone protein required for normal transmitter release. These unapposed receptors are not due to presynaptic retraction of synaptic boutons, since other presynaptic components are still apposed to the entire postsynaptic specialization. Instead, these data suggest that Brp localization is regulated at the level of individual release sites. Live imaging of glutamate receptors demonstrates that this disruption to active zone development is accompanied by abnormal postsynaptic development, with decreased formation of glutamate receptor clusters. Remarkably, inhibition of the serine-threonine kinase GSK-3β completely suppresses the active zone defect, as well as other synaptic morphology phenotypes associated with inhibition of PP2A. These data suggest that PP2A and GSK-3β function antagonistically to control active zone development, providing a potential mechanism for regulating synaptic efficacy at a single release site.

Original languageEnglish
Pages (from-to)11484-11494
Number of pages11
JournalJournal of Neuroscience
Volume29
Issue number37
DOIs
StatePublished - Sep 16 2009

Fingerprint Dive into the research topics of 'PP2A and GSK-3β act antagonistically to regulate active zone development'. Together they form a unique fingerprint.

  • Cite this